Zura Bio (ZURA) Cash from Operations (2022 - 2026)

Zura Bio's Cash from Operations history runs 5 years deep, the most recent figure standing at 18923000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations fell 71.05% year-over-year to 18923000.0 in Q1 2026; TTM through Mar 2026 was 72675000.0, a 112.77% decrease from a year earlier, with the FY2025 full-year figure at 64815000.0, down 130.86% from the prior year.
• Cash from Operations improved to 18923000.0 in Q1 2026 per ZURA's latest filing, from 22278000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 391000.0 in Q4 2022 and bottomed at 22278000.0 in Q4 2025.
• The 5-year median for Cash from Operations is 5173000.0 (2023), against an average of 7533529.41.
• Across the five-year window, Cash from Operations sank 1579.55% in 2023 and slipped 27.91% in 2024, its largest moves.
• Year by year, Cash from Operations stood at 391000.0 in 2022, then sank by 1136.57% to 4053000.0 in 2023, then tumbled by 167.06% to 10824000.0 in 2024, then slumped by 105.82% to 22278000.0 in 2025, then climbed by 15.06% to 18923000.0 in 2026.
• Per Business Quant, the three latest ZURA Cash from Operations figures stand at 18923000.0 (Q1 2026), 22278000.0 (Q4 2025), and 15444000.0 (Q3 2025).